Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

BMS scores first oesophageal cancer nod for Opdivo in Japan

Approval in Japan comes before US okay

- PMLiVE

Esperion gets FDA thumbs up for cholesterol drug Nexletol

Big comeback after previous trial fail

- PMLiVE

Lundbeck gets US approval for migraine drug at heart of Alder takeover

US regulator clears CGRP inhibitor under Vyepti trade name

- PMLiVE

BRIC markets

Why these countries offer an opportunity for pharma despite a slowdown

Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story

Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club.

Impetus Digital

Courageous Conversations ep.4: Five Key Benefits of the Internet of Medical Things

Impetus Digital

Courageous Conversations ep.3: Facial Recognition Technology and Its Impact on Healthcare

Impetus Digital

- PMLiVE

Bedrock Group celebrates a trio of new hires

Bedrock Group is gearing up for a year of incredible growth with the hire of two new Strategic Solutions Directors as well as an additional Account Manager.

Bedrock Healthcare Communications

- PMLiVE

Researchers discover new antibiotic using AI

First antibiotic to be discovered using this method

- PMLiVE

Tocagen merges with Forte Biosciences after brain cancer fail

New company will focus on Forte's lead skin disease drug

- PMLiVE

GSK pays $50m upfront to tap Immatics’ cell therapy platform

Deal focuses on T cell receptor therapies

- PMLiVE

Immutep spikes on trial of its LAG-3 drug with Keytruda

Impressive mid-stage results in NSCLC and HNSCC

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links